Skip to main content
OpenTrials

Clinical trial condition

Myelodysplastic-Myeloproliferative Diseases

Explore clinical trials studying Myelodysplastic-Myeloproliferative Diseases. Study availability and eligibility vary by location and protocol.

155 public trials 19 recruiting studies
Refine in advanced search Browse all conditions

Myelodysplastic-Myeloproliferative Diseases trial results

Completed

Total-Body Irradiation With or Without Fludarabine Phosphate Followed By Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer

NCT00075478

Conditions
Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, Aggressive Non-Hodgkin Lymphoma, +48 more
Locations
  • OHSU Cancer Institute-Southern Region Medford, Oregon, United States
  • Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States
  • LDS Hospital Salt Lake City, Utah, United States
  • VA Puget Sound Health Care System Seattle, Washington, United States
View Trial Details
Completed

Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder

NCT00755040

Conditions
Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +62 more
Locations
  • Stanford University Palo Alto, California, United States
  • Norwestern Memorial Hospital Chicago, Illinois, United States
  • Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States
  • M. D. Anderson Cancer Center Houston, Texas, United States
View Trial Details
Completed

American Ginseng in Treating Patients With Fatigue Caused by Cancer

NCT00719563

Conditions
Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +103 more
Locations
  • Mayo Clinic Scottsdale Scottsdale, Arizona, United States
  • Aurora Presbyterian Hospital Aurora, Colorado, United States
  • Boulder Community Hospital Boulder, Colorado, United States
  • Penrose Cancer Center at Penrose Hospital Colorado Springs, Colorado, United States
View all 326 locations
View Trial Details
Completed

Vatalanib in Treating Patients With Primary or Secondary Myelodysplastic Syndromes

NCT00072475

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +16 more
Locations
  • Tunnell Cancer Center at Beebe Medical Center Lewes, Delaware, United States
  • CCOP - Christiana Care Health Services Newark, Delaware, United States
  • Michael and Dianne Bienes Comprehensive Cancer Center at Holy Cross Hospital Fort Lauderdale, Florida, United States
  • Ella Milbank Foshay Cancer Center at Jupiter Medical Center Jupiter, Florida, United States
View all 68 locations
View Trial Details

Related conditions